Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price fell 14.6% during mid-day trading on Monday . The company traded as low as GBX 1.26 ($0.02) and last traded at GBX 1.26 ($0.02). 400,000 shares changed hands during trading, a decline of 70% from the average session volume of 1,329,828 shares. The stock had previously closed at GBX 1.48 ($0.02).
Cizzle Biotechnology Stock Up 3.7%
The stock’s 50-day moving average price is GBX 1.48 and its 200 day moving average price is GBX 1.58. The firm has a market capitalization of £5.55 million, a price-to-earnings ratio of -233.33 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- How to Use High Beta Stocks to Maximize Your Investing Profits
- CoreWeave and Madrigal’s Insider Trades Flash Bullish Signals
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- August’s Most Upgraded: 3 Stocks With +20 Price Target Increases
- Want to Profit on the Downtrend? Downtrends, Explained.
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
